82 FR 49663 - Yoon H. Choi, M.D.; Decision and Order

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 82, Issue 206 (October 26, 2017)

Page Range		49663-49665
FR Document		2017-23329
Federal Register, Volume 82 Issue 206 (Thursday, October 26, 2017)
[Federal Register Volume 82, Number 206 (Thursday, October 26, 2017)]
[Notices]
[Pages 49663-49665]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-23329]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. 17-28]


Yoon H. Choi, M.D.; Decision and Order

    On April 4, 2017, the Assistant Administrator, Division of 
Diversion Control, issued an Order to Show Cause to Yoon H. Choi, M.D. 
(Respondent), of Brockton, Massachusetts. The Show Cause Order proposed 
the revocation of Respondent's DEA Certificate of Registration as a 
practitioner, on the ground that he does not have authority to dispense 
controlled substances in Massachusetts, the State in which he is 
registered with the Agency. Show Cause Order, at 1.
    As to the Agency's jurisdiction, the Show Cause Order alleged that 
Respondent holds DEA Certificate of Registration No. BC6966381, which 
authorizes him to dispense controlled substances in schedules II 
through V as a practitioner, at the registered address of Steward 
Medical Group, One Pearl Street, Suite 2200, Brockton, Massachusetts. 
Id. The Show Cause Order alleged that this registration does not expire 
until August 31, 2018. Id.
    As to the substantive ground for the proceeding, the Show Cause 
Order alleged that ``[o]n January 5, 2017, the Commonwealth of 
Massachusetts Board of Registration in Medicine indefinitely suspended 
[his] medical license'' and that ``[t]his order remains in effect.'' 
Id. The Order thus alleged that Respondent is ``without authority to 
handle controlled substances in . . . Massachusetts, the [S]tate in 
which [he is] registered,'' that he is ``required to

[[Page 49664]]

possess authority from a [S]tate in order to obtain or retain a DEA 
registration,'' and that the Agency ``must revoke [his registration] 
based upon [his] lack of authority to handle controlled substances in . 
. . Massachusetts in violation of 21 U.S.C. 823(f) and 824(a)(3).'' \1\ 
Id. at 1-2.
---------------------------------------------------------------------------

    \1\ The Government's allegation erroneously suggests that 
Respondent's mere holding of a registration when his state authority 
had been suspended constitutes a violation of these provisions. 
These provisions are, however, grants of authority to the Attorney 
General to grant an application or revoke an existing registration. 
While these provisions (along with 21 U.S.C. 802(21)) manifest that 
a practitioner must hold state authority to obtain or maintain a 
registration, a practitioner does not violate the CSA simply by 
continuing to hold a registration after a State suspends or revokes 
his medical license. If, however, a practitioner prescribed 
controlled substances without holding state authority, he would 
violate a DEA regulation. See 21 CFR 1306.03(a)(1).
---------------------------------------------------------------------------

    The Show Cause Order also notified Respondent of his right to 
request a hearing on the allegations or to submit a written statement 
while waiving his right to a hearing, the procedure for electing either 
option, and the consequence for failing to elect either option. Id. at 
2. The Show Cause Order also notified Respondent of his right to submit 
a Corrective Action Plan under 21 U.S.C. 824(c)(2)(C). Id. at 2-3.
    On May 8, 2017, Respondent, through his counsel, timely requested a 
hearing.\2\ Resp.'s Hearing Request, at 1. The matter was placed on the 
docket of the Office of Administrative Law Judges and assigned to ALJ 
Charles Wm. Dorman, who issued a scheduling order the following day. 
Order Granting Summary Disposition, at 2. Under the ALJ's order, the 
Government was required to file any motion for summary disposition by 
May 16, 2017 and Respondent was required to file its opposition to the 
motion by ``2:00 p.m. EDT on May 26, 2017.'' Id.
---------------------------------------------------------------------------

    \2\ In his hearing request, Respondent also noted that he had 
filed a Corrective Action Plan with the Assistant Administrator, 
Diversion Control Division. Hearing Request, at 1 n.1.
---------------------------------------------------------------------------

    On May 16, 2017, the Government filed its motion for summary 
disposition. Therein, the Government maintained that it is undisputed 
that Respondent lacks authority to dispense controlled substances in 
Massachusetts, the State in which he is registered, and that therefore, 
he ``no longer meets the statutory definition of a practitioner.'' Mot. 
for Summ. Disp., at 3-4. As support for the motion, the Government 
attached a copy of the Final Decision and Order of the Commonwealth of 
Massachusetts Board of Registration in Medicine, which indefinitely 
suspended Respondent's medical license, effective January 5, 2017. The 
Government also attached a printout from the Board's Web site which it 
obtained on May 12, 2017 and which shows that Respondent's medical 
license was still suspended, as well as a copy of Respondent's 
Corrective Action Plan and his Certificate of Registration.
    Respondent did not file any pleading in response to the 
Government's motion. Order Granting Summary Disposition, at 2. 
Accordingly, on June 5, 2017, the ALJ granted the Government's motion, 
finding it undisputed that Respondent's state ``medical license is 
currently suspended'' and that he ``lacks state authorization to handle 
controlled substances in Massachusetts,'' the State in which he is 
registered. Id. at 5. Because ``DEA precedent requires that the 
Respondent cannot maintain a DEA registration for any location in that 
[S]tate,'' the ALJ recommended that I revoke his registration. Id. at 
5-6.
    Neither party filed exceptions to the ALJ's Order. Thereafter, on 
July 11, 2017, the ALJ forwarded the record to my Office for Final 
Agency Action.
    Upon review of the record, the former Acting Administrator noted 
that while Respondent had filed a Corrective Action Plan the record 
contained no evidence as to the Assistant Administrator's decision as 
to the adequacy of Respondent's Corrective Action Plan. Accordingly, on 
September 22, 2017, the former Acting Administrator issued an Order 
directing the Government to notify my Office of the status of 
Respondent's Corrective Action Plan, and in the event the Assistant 
Administrator had issued a decision on review of the Plan, to provide a 
copy of that decision. The former Acting Administrator provided 
Respondent with the right to reply to the Government's submission no 
later than five business days from the date of receipt of the 
Government's submission.
    On September 25, 2017, the Government submitted a copy of the 
former Assistant Administrator's letter of June 12, 2017 rejecting 
Respondent's Corrective Action Plan.\3\ The former Assistant 
Administrator also explained that ``there [was] no potential 
modification of [Respondent's Plan] that could or would alter my 
decision.'' Letter from Assistant Administrator, Diversion Control 
Division, to Respondent's Counsel (June 12, 2017). Respondent did not 
file a response to the Government's submission.
---------------------------------------------------------------------------

    \3\ A copy of this letter does not appear to have been 
previously provided to the ALJ.
---------------------------------------------------------------------------

    Having considered the record in its entirety, I adopt the ALJ's 
factual finding that Respondent's Massachusetts medical license has 
been suspended, as well as his legal conclusion that he currently lacks 
authority to dispense controlled substances in Massachusetts and thus, 
he ``cannot maintain'' his DEA registration. I also adopt the ALJ's 
recommended Order that I revoke his registration. I make the following 
factual findings.

Findings

    Respondent is the holder of DEA Certificate of Registration No. 
BC6966381, pursuant to which he is authorized to dispense controlled 
substances in schedules II through V as a practitioner, at the 
registered address of Steward Medical Group Brockton, One Pearl Street 
Suite 2200, Brockton, MA 02301. GX 1. This registration does not expire 
until August 31, 2018.
    Respondent is also the holder of Medical License No. 206555 issued 
by the Commonwealth of Massachusetts Board of Registration in Medicine. 
GX 2, at Attachment B. However, on January 5, 2017, the Board issued a 
Final Decision and Order which ``indefinitely suspended'' his medical 
license. GX 2, at Attachment A. According to the Board's Physician 
Profile Web page of which I take Official Notice, see 5 U.S.C. 
556(e),\4\ the suspension remains in effect as of the date of this 
Decision and Order.\5\
---------------------------------------------------------------------------

    \4\ Respondent may refute this finding by filing a properly 
supported motion for reconsideration with the Office of the 
Administrator within 10 business days of the date of this Decision 
and Order.
    \5\ While the Board's Order provides that ``Respondent may 
petition to stay [the] suspension upon successful completion of a 
clinical skills assessment by a board-approved entity and entry into 
a Probation Agreement,'' the suspension remains in effect as of the 
date of this Order.
---------------------------------------------------------------------------

Discussion

    Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized 
to suspend or revoke a registration issued under section 823, ``upon a 
finding that the Registrant . . . has had his State license . . . 
suspended [or] revoked . . . by competent State authority and is no 
longer authorized by State law to engage in the . . . dispensing of 
controlled substances.'' Moreover, DEA has held repeatedly that the 
possession of authority to dispense controlled substances under the 
laws of the State in which a practitioner engages in professional 
practice is a fundamental condition for obtaining and maintaining a 
practitioner's registration. See, e.g., James L. Hooper, 76 FR 71371 
(2011), pet. for rev. denied, 481 Fed Appx. 826 (4th Cir. 2012).
    This rule derives from the text of two provisions of the CSA. 
First, Congress defined ``the term `practitioner' [to] mean[] a . . . 
physician . . . or other

[[Page 49665]]

person licensed, registered or otherwise permitted, by . . . the 
jurisdiction in which he practices . . . to distribute, dispense, [or] 
administer . . . a controlled substance in the course of professional 
practice.'' 21 U.S.C. 802(21). Second, in setting the requirements for 
obtaining a practitioner's registration, Congress directed that ``[t]he 
Attorney General shall register practitioners . . . if the applicant is 
authorized to dispense . . . controlled substances under the laws of 
the State in which he practices.'' 21 U.S.C. 823(f). Because Congress 
has clearly mandated that a physician possess state authority in order 
to be deemed a practitioner under the Act, DEA has held that revocation 
of a practitioner's registration is the appropriate sanction whenever 
he is no longer authorized to dispense controlled substances under the 
laws of the State in which he practices medicine. See, e.g., Calvin 
Ramsey, 76 FR 20034, 20036 (2011); Sheran Arden Yeates, M.D., 71 FR 
39130, 39131 (2006); Dominick A. Ricci, 58 FR 51104, 51105 (1993); 
Bobby Watts, 53 FR 11919, 11920 (1988); see also Hooper v. Holder, 481 
Fed. Appx. at 828.
    As a consequence of the Board's Final Decision and Order, 
Respondent is not currently authorized to dispense controlled 
substances in Massachusetts, the State in which he is registered. 
Because the CSA makes clear that the possession of authority to 
dispense controlled substances under the laws of the State in which a 
practitioner engages in professional practice is a fundamental 
condition for both obtaining and maintaining a practitioner's 
registration, it is of no consequence that the Board's Order provided 
that he may petition to stay the suspension upon meeting certain 
conditions. Cf. Hooper v. Holder, 481 F. App'x at 828 (upholding 
revocation of a physician's registration as based on a reasonable 
interpretation of the CSA, notwithstanding that the physician's medical 
license was subject to a suspension of known duration); see also James 
L. Hooper, 76 FR 71371, 71371-72 (2011).\6\ As of this date, Respondent 
is not currently authorized to dispense controlled substances in 
Massachusetts, and therefore, he is not entitled to maintain his 
registration in that State. Accordingly, I will order that his 
registration be revoked and that any pending application to renew his 
registration, or for any other registration in the Commonwealth of 
Massachusetts be denied.
---------------------------------------------------------------------------

    \6\ By contrast, Respondent's suspension is of unknown duration.
---------------------------------------------------------------------------

Order

    Pursuant to the authority vested in me by 21 U.S.C. 824(a), as well 
as 28 CFR 0.100(b), I order that DEA Certificate of Registration No. 
BC6966381 issued to Yoon Choi, M.D., be, and it hereby is, revoked. 
Pursuant to the authority vested in me by 21 U.S.C. 823(f), I further 
order that any application of Yoon Choi, M.D., to renew or modify this 
registration, or for any other registration in the Commonwealth of 
Massachusetts, be, and it hereby is, denied. This Order is effective 
November 27, 2017.

    Dated: October 17, 2017.
Robert W. Patterson,
Acting Administrator.
[FR Doc. 2017-23329 Filed 10-25-17; 8:45 am]
 BILLING CODE 4410-09-P
Federal Register / Vol. 82, No. 206 / Thursday, October 26, 2017 / Notices 49663

noon the next day pursuant to § 210.4(f) Issued: October 20, 2017. Research, Inc., #100 Carr 198, Industrial
of the Commission’s Rules of Practice Lisa R. Barton, Park, Juncos, Puerto Rico 00777–3873
and Procedure (19 CFR 210.4(f)). Secretary to the Commission. applied to be registered as an importer
Submissions should refer to the docket [FR Doc. 2017–23233 Filed 10–25–17; 8:45 am] of hydromorphone (9150), a basic class
number (‘‘Docket No. 3266’’) in a BILLING CODE 7020–02–P
of controlled substance in schedule II.
prominent place on the cover page and/ The company plans to import the
or the first page. (See Handbook for listed controlled substance in finished
Electronic Filing Procedures, Electronic DEPARTMENT OF JUSTICE dosage form for clinical trials, research
Filing Procedures 1). Persons with and analytical purposes.
questions regarding filing should Drug Enforcement Administration The import of this class of controlled
contact the Secretary (202–205–2000). substance will be granted only for
[Docket No. DEA–392] analytical testing, research, and clinical
Any person desiring to submit a
Importer of Controlled Substances trials. This authorization does not
document to the Commission in
Application: Galephar Pharmaceutical extend to the import of a finished FDA
confidence must request confidential approved or non-approved dosage form
treatment. All such requests should be Research, Inc.
for commercial sale.
directed to the Secretary to the
ACTION: Notice of application. Dated: October 18, 2017.
Commission and must include a full
statement of the reasons why the Demetra Ashley,
DATES: Registered bulk manufacturers of
Commission should grant such Acting Assistant Administrator.
the affected basic classes, and
treatment. See 19 CFR 201.6. Documents applicants therefore, may file written [FR Doc. 2017–23328 Filed 10–25–17; 8:45 am]
for which confidential treatment by the comments on or objections to the BILLING CODE 4410–09–P
Commission is properly sought will be issuance of the proposed registration on
treated accordingly. All such requests or before November 27, 2017. Such
should be directed to the Secretary to DEPARTMENT OF JUSTICE
persons may also file a written request
the Commission and must include a full for a hearing on the application on or Drug Enforcement Administration
statement of the reasons why the before November 27, 2017.
Commission should grant such ADDRESSES: Written comments should [Docket No. 17–28]
treatment. See 19 CFR 201.6. Documents be sent to: Drug Enforcement
for which confidential treatment by the Yoon H. Choi, M.D.; Decision and
Administration, Attention: DEA Federal
Commission is properly sought will be Order
Register Representative/DRW, 8701
treated accordingly. All information, Morrissette Drive, Springfield, Virginia On April 4, 2017, the Assistant
including confidential business 22152. All requests for hearing must be Administrator, Division of Diversion
information and documents for which sent to: Drug Enforcement Control, issued an Order to Show Cause
confidential treatment is properly Administration, Attn: Administrator, to Yoon H. Choi, M.D. (Respondent), of
sought, submitted to the Commission for 8701 Morrissette Drive, Springfield, Brockton, Massachusetts. The Show
purposes of this Investigation may be Virginia 22152. All requests for hearing Cause Order proposed the revocation of
disclosed to and used: (i) By the should also be sent to: (1) Drug Respondent’s DEA Certificate of
Commission, its employees and Offices, Enforcement Administration, Attn: Registration as a practitioner, on the
and contract personnel (a) for Hearing Clerk/LJ, 8701 Morrissette ground that he does not have authority
developing or maintaining the records Drive, Springfield, Virginia 22152; and to dispense controlled substances in
of this or a related proceeding, or (b) in (2) Drug Enforcement Administration, Massachusetts, the State in which he is
internal investigations, audits, reviews, Attn: DEA Federal Register registered with the Agency. Show Cause
and evaluations relating to the Representative/DRW, 8701 Morrissette Order, at 1.
programs, personnel, and operations of Drive, Springfield, Virginia 22152. As to the Agency’s jurisdiction, the
the Commission including under 5 SUPPLEMENTARY INFORMATION: The Show Cause Order alleged that
U.S.C. Appendix 3; or (ii) by U.S. Attorney General has delegated his Respondent holds DEA Certificate of
government employees and contract authority under the Controlled Registration No. BC6966381, which
personnel,2 solely for cybersecurity Substances Act to the Administrator of authorizes him to dispense controlled
purposes. All nonconfidential written the Drug Enforcement Administration substances in schedules II through V as
submissions will be available for public (DEA), 28 CFR 0.100(b). Authority to a practitioner, at the registered address
inspection at the Office of the Secretary exercise all necessary functions with of Steward Medical Group, One Pearl
and on EDIS.3 respect to the promulgation and Street, Suite 2200, Brockton,
This action is taken under the implementation of 21 CFR part 1301, Massachusetts. Id. The Show Cause
incident to the registration of Order alleged that this registration does
authority of section 337 of the Tariff Act
manufacturers, distributors, dispensers, not expire until August 31, 2018. Id.
of 1930, as amended (19 U.S.C. 1337),
importers, and exporters of controlled As to the substantive ground for the
and of §§ 201.10 and 210.8(c) of the
substances (other than final orders in proceeding, the Show Cause Order
Commission’s Rules of Practice and
connection with suspension, denial, or alleged that ‘‘[o]n January 5, 2017, the
Procedure (19 CFR 201.10, 210.8(c)).
revocation of registration) has been Commonwealth of Massachusetts Board
By order of the Commission. redelegated to the Assistant of Registration in Medicine indefinitely
ethrower on DSK3G9T082PROD with NOTICES

Administrator of the DEA Diversion suspended [his] medical license’’ and
1 Handbook for Electronic Filing Procedures:
Control Division (‘‘Assistant that ‘‘[t]his order remains in effect.’’ Id.
https://www.usitc.gov/documents/handbook_on_ Administrator’’) pursuant to section 7 of The Order thus alleged that Respondent
filing_procedures.pdf.
2 All contract personnel will sign appropriate
28 CFR part 0, appendix to subpart R. is ‘‘without authority to handle
nondisclosure agreements. In accordance with 21 CFR controlled substances in . . .
3 Electronic Document Information System 1301.34(a), this is notice that on August Massachusetts, the [S]tate in which [he
(EDIS): https://edis.usitc.gov. 2, 2017, Galephar Pharmaceutical is] registered,’’ that he is ‘‘required to

VerDate Sep<11>2014 17:29 Oct 25, 2017 Jkt 244001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\26OCN1.SGM 26OCN1
Federal Register / Vol. 82, No. 206 / Thursday, October 26, 2017 / Notices 49665

person licensed, registered or otherwise in the Commonwealth of Massachusetts As the first substantive ground for the
permitted, by . . . the jurisdiction in be denied. proceeding, the Show Cause Order
which he practices . . . to distribute, alleged that Respondent is ‘‘currently
Order
dispense, [or] administer . . . a without authority to handle controlled
controlled substance in the course of Pursuant to the authority vested in me substances in Arizona.’’ GX 4, at 1. It
professional practice.’’ 21 U.S.C. by 21 U.S.C. 824(a), as well as 28 CFR alleged that, on December 21, 2016,
802(21). Second, in setting the 0.100(b), I order that DEA Certificate of Respondent ‘‘entered into an Interim
requirements for obtaining a Registration No. BC6966381 issued to Consent Agreement for Practice
practitioner’s registration, Congress Yoon Choi, M.D., be, and it hereby is, Restriction with the Arizona Medical
directed that ‘‘[t]he Attorney General revoked. Pursuant to the authority Board’’ which ‘‘prohibited [Respondent]
shall register practitioners . . . if the vested in me by 21 U.S.C. 823(f), I from engaging in the practice of
applicant is authorized to dispense . . . further order that any application of medicine in the State of Arizona . . .
controlled substances under the laws of Yoon Choi, M.D., to renew or modify until he applies to the Executive
the State in which he practices.’’ 21 this registration, or for any other Director and receives permission to do
U.S.C. 823(f). Because Congress has registration in the Commonwealth of so.’’ GX 4, at 1 and GX 3, at 5 (Interim
clearly mandated that a physician Massachusetts, be, and it hereby is, Consent Agreement For Practice
denied. This Order is effective Restriction), respectively. The Show
possess state authority in order to be
November 27, 2017. Cause Order alleged that Respondent
deemed a practitioner under the Act,
was ‘‘still currently prohibited from
DEA has held that revocation of a Dated: October 17, 2017.
practicing medicine in the state in
practitioner’s registration is the Robert W. Patterson, which . . . [he is] registered with the
appropriate sanction whenever he is no Acting Administrator. DEA . . . [and] therefore, the DEA must
longer authorized to dispense controlled [FR Doc. 2017–23329 Filed 10–25–17; 8:45 am] revoke . . . [his] DEA . . . [registration]
substances under the laws of the State BILLING CODE 4410–09–P based upon . . . [his] lack of authority
in which he practices medicine. See, to handle controlled substances in the
e.g., Calvin Ramsey, 76 FR 20034, 20036 State of Arizona.’’ GX 4, at 2 (citing 21
(2011); Sheran Arden Yeates, M.D., 71 DEPARTMENT OF JUSTICE U.S.C. 802(21), 823(f), and 824(a)(3)).
FR 39130, 39131 (2006); Dominick A. As the second substantive ground for
Ricci, 58 FR 51104, 51105 (1993); Bobby Drug Enforcement Administration the proceeding, the Show Cause Order
Watts, 53 FR 11919, 11920 (1988); see alleged that the Arizona Attorney
also Hooper v. Holder, 481 Fed. Appx. Harinder Takyar, M.D.; Decision and General’s Office and the Pinal County
at 828. Order (Arizona) Task Force ‘‘initiated an
As a consequence of the Board’s Final On January 24, 2017, the Assistant investigation of . . . [Respondent’s]
Decision and Order, Respondent is not Administrator, Diversion Control medical practice after receiving
currently authorized to dispense Division, Drug Enforcement information from a cooperating source
controlled substances in Massachusetts, Administration (hereinafter, DEA or that . . . [he] routinely prescribed large
the State in which he is registered. Government), issued an Order to Show quantities of oxycodone, a Schedule II
controlled substance, without
Because the CSA makes clear that the Cause to Harinder Takyar, M.D.
performing an examination.’’ GX 4, at 2.
possession of authority to dispense (hereinafter, Respondent) of Mesa,
After summarizing two law enforcement
controlled substances under the laws of Arizona. GX 4. The Show Cause Order
officers’ undercover visits to
the State in which a practitioner engages proposed the revocation of
Respondent’s medical practice, the
in professional practice is a Respondent’s Certificate of Registration
Show Cause Order alleged that,
fundamental condition for both on the grounds that Respondent does
concerning the first undercover officer,
obtaining and maintaining a ‘‘not have authority to handle controlled
Respondent prescribed schedule II and
practitioner’s registration, it is of no substances in the State of Arizona,’’ the
IV controlled substances ‘‘after
consequence that the Board’s Order State in which he is registered, and that
conducting only a cursory medical
provided that he may petition to stay Respondent’s ‘‘registration would be examination[, or no physical
the suspension upon meeting certain inconsistent with the public interest.’’ examination but falsely documenting a
conditions. Cf. Hooper v. Holder, 481 F. GX 4, at 1 (citing 21 U.S.C. 823(f), full physical exam] . . . without
App’x at 828 (upholding revocation of a 824(a)(3) and (4)). inquiring about whether the agent
physician’s registration as based on a As to the Agency’s jurisdiction, the experienced sleeplessness, anxiety, or
reasonable interpretation of the CSA, Show Cause Order alleged that panic[, and without] . . . properly
notwithstanding that the physician’s Respondent holds DEA Certificate of execut[ing] . . . a prescription . . . as
medical license was subject to a Registration No. BT9321150 which required by 21 CFR 1306.05(a) by not
suspension of known duration); see also authorizes him to dispense controlled listing the full address of the patient on
James L. Hooper, 76 FR 71371, 71371– substances in schedules II through V as the face of the prescription . . . [or]
72 (2011).6 As of this date, Respondent a practitioner at the registered address maintain[ing] an adequate patient
is not currently authorized to dispense of 9341 East McKellips Road, Mesa, chart.’’ GX 4, at 2–3.
controlled substances in Massachusetts, Arizona 85207. GX 4, at 1. See also GX Concerning the second undercover
and therefore, he is not entitled to 1 (Controlled Substance Registration officer, the Show Cause Order alleged
maintain his registration in that State. Certificate) (including ‘‘Reform that Respondent prescribed a schedule
ethrower on DSK3G9T082PROD with NOTICES

Accordingly, I will order that his Physicians’’) and GX 2, at 1 II controlled substance the first time
registration be revoked and that any (Certification of Registration History) ‘‘despite the agent informing . . .
pending application to renew his (9341 E McKellips Road, Mesa, AZ [Respondent] that he felt no pain during
registration, or for any other registration 85207–8520). The Show Cause Order . . . [Respondent’s] brief examination of
alleged that this registration expires on him . . . [, and a second time without]
6 By contrast, Respondent’s suspension is of November 30, 2019. GX 4, at 1. See also conduct[ing] a physical exam . . . and
unknown duration. GX 2, at 1. falsely documenting a full physical

VerDate Sep<11>2014 17:29 Oct 25, 2017 Jkt 244001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 E:\FR\FM\26OCN1.SGM 26OCN1
Document Created: 2018-10-25 10:13:20
Document Modified: 2018-10-25 10:13:20
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		82 FR 49663
82 FR 49663 - Yoon H. Choi, M.D.; Decision and Order

DEPARTMENT OF JUSTICEDrug Enforcement Administration

Federal Register Volume 82, Issue 206 (October 26, 2017)

DEPARTMENT OF JUSTICE
Drug Enforcement Administration
